Processing your payment...
Please do not close your browser.

DNA Damage Response Drugs Market- Global Growth, Trends and Forecast (2022-2029) By Drug (ZEJULA, Rubraca, Talzenna) , By Application (Ovarian Cancer, Breast Cancer, Others) and By Regions

28 Jun, 2022 | 111 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Over the forecast period, the DNA Damage Response Drugs Market will register a CAGR of 20.8 % in terms of revenue and the global market size will reach USD 24,751 Million by 2029.

DNA Damage Response Drugs Market Overview

DNA damage is an aberrant DNA structure that causes changes to the genetic material's structure and hinders the replication mechanism from working properly. A cell uses a mechanism called DNA repair to detect and repair damage to the DNA molecules that encode its genome. One of the biggest causes of mortality worldwide is cancer. Numerous cancer disorders affect a big number of people. As a result, the worldwide market for DNA repair medications is projected to expand as the incidence of cancer among the population rises. For instance, the World Health Organization estimates that there were 9.6 million cancer-related deaths and 18.1 million new cases worldwide in 2018.

Additionally, it is projected that increased demand and the adoption of next-generation technologies will propel the market. Several important firms are investing in research and development and implementing initiatives to create new products. This aspect is projected to accelerate the market expansion for DNA repair medications.

What is our DNA Damage Response Drugs Market report scope?

 

Report Attributes

 

 

Report Details

 

Forecast Period 2022 to 2029

 

CAGR of 20.8% during the review period (2022 to 2029).

 

By Type

  • ZEJULA
  • Lynparza
  • Rubraca
  • Talzenna

 

By Mechanism of Action

 

 

 

 

  • Base Excision Repair (BER)
  • Homologous Recombination (HR)
  • Mismatch Repair (MMR)
  • Others

By Application

  • Ovarian Cancer
  • Breast Cancer
  • Others

 

 

 

By Companies

  • Artios Pharma
  • AstraZeneca
  • Johnson & Johnson Services, Inc.
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline
  • Clovis Oncology
  • Pfizer Inc.

 

 

 

Regions Covered

 

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

 

 

 

 

 

 

 

Countries Covered

  • US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America

 

Historical Year

 

 

2017 to 2021

Forecast Year

2022 to 2029

Number of Pages

111

 

Customization Available

 

Yes, the report can be customized as per your needs

Who are the Major Players in DNA Damage Response Drugs Market?

Market Growth Reports lists out all the DNA Damage Response Drugs Market companies that are presently striving to reduce the impact of Covid-19 pandemic on the Market- Artios Pharma, Merck Group, AstraZeneca, Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline, Clovis Oncology, Pfizer Inc, Others

Industry News:

Artios Pharma and Novartis Set to Collaborate to Develop Next-Generation DDR Therapies

In order to create next-generation DDR targets that will work in conjunction with Novartis' radioligand therapies, Artios Pharma, a firm dedicated to creating precision medicine–based therapeutics based on DNA damage response (DDR) mechanisms, has entered into a worldwide research cooperation.

What are the major Types, Mechanisms of Action, and Applications of the DNA Damage Response Drugs Market?

By Type, it is segmented into

  • ZEJULA
  • Lynparza
  • Rubraca
  • Talzenna  

By Mechanism of Action, it is segmented into

  • Base Excision Repair (BER)
  • Homologous Recombination (HR)
  • Mismatch Repair (MMR)
  • Others

By Application, it is segmented into

  • Ovarian Cancer
  • Breast Cancer
  • Others

DNA Damage Response Drugs Market Regional Analysis

The market for DNA repair medications will be dominated by North America. The market for DNA repair medications is anticipated to be dominated by North America. The region's market is expected to grow as a hub for major businesses and as a result of the early acceptance of technologically sophisticated items, new products will be introduced. The market for DNA repair medications is anticipated to be dominated by Asia Pacific. During the projection period, the market in the area is anticipated to expand quickly. The region's cancer market is anticipated to rise as a result of increased awareness, government efforts, and cancer prevalence.

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Middle East & Africa
    • Latin America
  1. INTRODUCTION
    • MARKET DEFINITION
    • MARKET DYNAMICS
    • MARKET SEGMENTATION
    • REPORT TIMELINES
    • KEY STAKEHOLDERS
  2. RESEARCH METHODOLOGY
    • DATA MINING
      • SECONDARY RESEARCH
      • PRIMARY RESEARCH
      • SUBJECT MATTER EXPERT ADVICE
    • QUALITY CHECK
    • FINAL REVIEW
      • DATA TRIANGULATION
      • BOTTOM-UP APPROACH
      • TOP-DOWN APPROACH
      • RESEARCH FLOW
  3. EXECUTIVE SUMMARY
    • INTRODUCTION
    • GLOBAL DNA DAMAGE RESPONSE DRUGS MARKET BY TYPES
    • GLOBAL DNA DAMAGE RESPONSE DRUGS MARKET BY MECHANISM OF ACTION
    • GLOBAL DNA DAMAGE RESPONSE DRUGS MARKET BY APPLICATION
  4. MARKET DYNAMICS
    • DRIVERS
      • INCREASING GERIATRIC POPULATION AND PREVALENCE OF CHRONIC DISEASE
    • RESTRAINTS
      • STRINGENT ENVIRONMENTAL REGULATIONS
      • HIGH COST OF MATERIALS
    • OPPORTUNITIES
      • DNA DAMAGE RESPONSE DRUGS GROWTH
    • APPLICATION OF DNA DAMAGE RESPONSE DRUGS IMPACT ON COVID 19
  5. GLOBAL DNA DAMAGE RESPONSE DRUGS MARKET, BY TYPES
    • INTRODUCTION
    • ZEJULA
    • LYNPARZA
    • RUBRACA
    • TALZENNA
  6. GLOBAL DNA DAMAGE RESPONSE DRUGS MARKET, BY MECHANISM OF ACTION
    • INTRODUCTION
    • BASE EXCISION REPAIR (BER)
    • HOMOLOGOUS RECOMBINATION (HR)
    • MISMATCH REPAIR (MMR)
    • OTHERS
  7. GLOBAL DNA DAMAGE RESPONSE DRUGS MARKET, BY APPLICATION
    • INTRODUCTION
    • OVARIAN CANCER
    • BREAST CANCER
    • OTHERS
  8. GLOBAL DNA DAMAGE RESPONSE DRUGS MARKET, BY REGION
    • NORTH AMERICA
      • US
      • CANADA
      • MEXICO
    • EUROPE
      • GERMANY
      • FRANCE
      • UK
      • ITALY
      • RUSSIA
      • REST OF EUROPE
    • APAC
      • CHINA
      • SOUTH KOREA
      • JAPAN
      • INDIA
      • AUSTRALIA
      • ASEAN
      • REST OF APAC
    • MIDDLE EAST AND AFRICA
      • SAUDI ARABIA
      • UAE
      • SOUTH AFRICA
      • TURKEY
      • REST OF MEA
    • SOUTH AMERICA
      • BRAZIL
      • REST OF MEA
      • ARGENTINA
      • REST OF SOUTH AMERICA
  9. COMPETITIVE LANDSCAPE
    • MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,
    • AND AGREEMENTS
      • KEY DEVELOPMENT
    • MARKET SHARE PERCENT/RANKING ANALYSIS
    • STRATEGIES ADOPTED BY LEADING PLAYERS
  10. COMPANY PROFILES
    • BUSINESS OVERVIEW
    • COMPANY SNAPSHOT
    • PRODUCT BENCHMARKING
    • STRATEGIC INITIATIVES
  1. ARTIOS PHARMA
  2. ASTRAZENECA
  3. JOHNSON & JOHNSON SERVICES, INC.
  4. BRISTOL-MYERS SQUIBB COMPANY
  5. GLAXOSMITHKLINE
  6. CLOVIS ONCOLOGY
  7. PFIZER INC

 

 

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Request A Sample

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Korean Institute of Tuberculosis
  • Sanyo chemical Industries LTD
  • Novartis
  • Hisamitsu
  • Pfizer
  • AbbVie
  • RevHealth
  • Zeon Corporation
  • Abbott (Established Pharmaceutical Products)
  • Sinopharm (pharmaceutical distribution segment)
  • Takeda Pharmaceutical
  • Gilead Sciences
  • Sartorius
  • Zavation
  • Permobil
  • Ansell
  • Cefla